When women ask their doctors about the cause and possible treatment for a heavy period, too many healthcare providers are quick to dismiss a bleeding disorder as a possible culprit.
The NHF Inhibitor Education Summits provided an opportunity to learn more about having hemophilia with an inhibitor—and to connect with people familiar with those challenges.
The recommendations are intended to set standards of care for the treatment of hemophilia and von Willebrand disease, and to set guidelines for blood safety.
Only when all women are aware of the symptoms of bleeding disorders can we achieve success—that’s the idea behind Victory for Women, NHF’s new women’s health and blood disorders initiative.
